Loading...
Loading...
Shares of MannKind
MNKD are higher on the session by 3.12%, currently trading at $2.31. The stock has been moving largely lower over the past two months and is currently trading below the 50-day moving average.
Options traders are focusing on puts today. The strike seeing the heaviest action is the May 2012 $4.50 put, which has traded 508 times on open interest of 118 contracts.
Put volume is outpacing call volume by 3 to 1.
MannKind Corporation is a biopharmaceutical company focused on the discovery, development and commercialization of therapeutic products for diseases, such as diabetes and cancer.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date of Trade | ticker | Put/Call | Strike Price | DTE | Sentiment |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in